Related Experiment Videos

Morbidity among human immunodeficiency virus-1-infected and -uninfected African children

T E Taha1, S M Graham, N I Kumwenda

  • 1Infectious Diseases Program, Department of Epidemiology, School of Hygiene and Public Health, Johns Hopkins University, Baltimore, Maryland, USA.ttaha@jhsph.edu

Pediatrics
|January 11, 2000
PubMed

Insights

Human immunodeficiency virus (HIV)-infected African children experienced significantly higher morbidity and mortality rates. Rapid disease progression necessitates urgent development of effective management strategies to reduce illness in these vulnerable children.

Area of Science:

  • Pediatrics
  • Infectious Diseases
  • Public Health

Background:

  • Human immunodeficiency virus (HIV) infection presents unique challenges in pediatric populations, particularly in resource-limited settings.
  • Understanding morbidity patterns is crucial for effective management and improved outcomes in HIV-exposed and HIV-infected children.

Purpose of the Study:

  • To investigate and compare the patterns of morbidity and mortality in HIV-infected versus HIV-uninfected African children during late infancy and early childhood.
  • To identify factors associated with increased morbidity and mortality in this cohort.

Main Methods:

  • A prospective study was conducted in Malawi, following children from infancy to approximately 36 months of age.
  • Morbidity and mortality data were collected via questionnaires every 3 months, with physical examinations every 6 months.
  • Age-adjusted and Kaplan-Meier analyses were used to compare outcomes between HIV-infected and HIV-uninfected children.

Main Results:

  • HIV-infected children exhibited significantly higher age-adjusted morbidity rates compared to HIV-uninfected children.
  • By age 3, 89% of HIV-infected children had died, with conditions like splenomegaly, oral thrush, and developmental delay predicting mortality.
  • Immunization rates were generally high across all groups, but HIV-infected children showed greater immunosuppression.

Conclusions:

  • The study highlights a high frequency of diseases and a rapid progression from HIV disease to death in infected children.
  • There is a critical need for management strategies to effectively reduce morbidity and improve survival in HIV-infected children.
  • Early identification and intervention for conditions like oral thrush and developmental delay are vital for improving prognosis.
Abstract

Related Concept Videos